SB 211475

Known as: SB-211475 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1994-1998
01219941998

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
The aim of this study was to investigate the effect of SB 211475, a metabolite of carvedilol with weak alpha1-adrenoceptor… (More)
Is this relevant?
1998
1998
1 Reactive oxygen species have been demonstrated to play a critical role in post-ischaemic tissue injury. The present experiment… (More)
Is this relevant?
1994
1994
The antioxidant effects of SB 211475, a metabolite of carvedilol, a novel antihypertensive agent, were studied and compared with… (More)
Is this relevant?